vimarsana.com
Home
Live Updates
BD Receives 510(k) Clearance for COVID-19, Influenza A/B, RS
BD Receives 510(k) Clearance for COVID-19, Influenza A/B, RS
BD Receives 510(k) Clearance for COVID-19, Influenza A/B, RSV Molecular Combination Test
/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced U.S. Food and Drug Administration...
Related Keywords
United States ,
Francesca Demartino ,
Troy Kirkpatrick ,
Administration For Strategic Preparedness ,
Us Department Of Health ,
Development Authority ,
Biomedical Advanced Research ,
Drug Administration ,
Human Services ,
Linkedin ,
Bd Respiratory Viral Panel ,
Single Test ,
System Identifies ,
Viral Panel ,
Respiratory Syncytial Virus ,
Emergency Use Authorization ,
Nikos Pavlidis ,
Strategic Preparedness ,